In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gynesonics, Inc

https://gynesonics.com/us/

Latest From Gynesonics, Inc

US Payors Expand Patient Access To Gynesonics’ Uterine Fibroid Treatment

Gynesonics' Sonata System uses radiofrequency energy to ablate fibroids under real-time intrauterine sonography guidance.

Reimbursement Gynecology & Urology

Medtech Execs On The Move, June 2016

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Execs On The Move, June 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

Device/Diagnostics Quarterly Deal Statistics, Q3 2015

$1.4 billion in Q3 device financing was slightly lower than Q2's $1.8 billion with just one IPO versus Q2's seven. Acquisitions reached a high of $23 billion and diagnostics financing increased 30% over Q2 to $1 billion, while M&A activity at $1.2 billion showed a sharp decline from the previous quarter's $15.6 billion.

Medical Device Deals
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
      • Ultrasound
UsernamePublicRestriction

Register